In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabetogen Biosciences Inc.

www.diabetogen.com

Latest From Diabetogen Biosciences Inc.

Tackling Diabetes and Obesity

The growing incidence of these diseases, and their complexity, provide opportunities for a number of different approaches
BioPharmaceutical

Diabetogen Biosciences Inc.

Diabetogen Biosciences' therapies target the autoimmune component of Type I diabetes and may help prevent onset of the disease.
BioPharmaceutical Research and Development Strategies

Start-Up Previews (7/01)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups focus on Biorepositories (Asterand Inc., BioSample Inc., Genomics Collaborative Inc., TissueInformatics Inc.); Therapeutics for Diabetes and Obesity (Arexis AB, Diabetogen Biosciences Inc., PanCel Corp., Rademacher Group Ltd.); and Orthopedic and Surgical Devices (Ascension Orthopedics Inc., Coapt Systems Inc., NuVasive Inc., SpringFlex Orthopedics Inc.). Plus these Selected Start-Ups across Health Care: Achillion Pharmaceuticals Inc., GeneProt Inc., MonitorForHire.com and Targacept Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Diabetogen Biosciences Inc.
  • Senior Management
  • William A McGinnis, Pres. & CEO
    Michael F Crowley, CFO
    Terry L Delovitch, PhD, CSO
    Hamza Suria, Dir., Bus. Dev.
  • Contact Info
  • Diabetogen Biosciences Inc.
    Phone: (519) 663-3972
    100 Perth Dr.
    P.O. Box 5015 London, N6A 5K8
    Canada
UsernamePublicRestriction

Register